Found 12 matching trials
The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes
N/ADuring the study, members of different online and offline communities will ...
Location
MEBO Research, Inc
COVID-19 Vaccines Safety Tracking (CoVaST)
N/AThis project aims to monitor the side effects of COVID-19 vaccines worldwid...
Location
American College of Physicians
Efficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC]
PHASE4PRIBIVAC will assess a heterologous prime-boost-boost strategy in compariso...
Location
National Centre for Infectious Diseases (NCID)
Phase III Study of BBV154 Intranasal Vaccine in Healthy Volunteers
PHASE3Group 1 (BBV154): In this group, 3000 participants will be recruited, rando...
Location
VIMS (Visakha Institute of Medical Sciences)
Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults
PHASE2A randomized, observer-blind, placebo-controlled immuno-bridging, and broad...
Safety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19
PHASE1The study is designed to evaluate the safety, reactogenicity, and immunogen...
BBV152/BBV154 Heterologus Prime-Boost Study
PHASE2All participants will be assessed for immunogenicity and safety endpoints a...
Location
The INCLEN Trust International/Guru Nanak Hospital
Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers
PHASE1Double blind, Multi-Centre study to evaluate the safety, reactogenicity, to...
Location
King George Hospital
Phase 3 Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose
PHASE3A total sample size of 875 healthy volunteers ages ≥18 years will be recrui...
Location
All India Institute of Medical Sciences
An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers
PHASE3The BBV152 vaccine is being developed to prevent COVID-19, the disease resu...
Location
Pt BD SHARMA,PGIMS/UHS